학술논문
방사선 치료 시 종양선량을 예측하는 방법에 관한 연구
이용수 5
- 영문명
- A study on in-vivo dosimetry for radiation therapy
- 발행기관
- 고려대학교 보건과학연구소
- 저자명
- 최종학(JongHak Choi) 고현식(HyunSik Ko) 이병구(BungGu Lee) 김유현(YouHyun Kim)
- 간행물 정보
- 『보건과학논집』保健科學論集 Vol.29 No.2, 31~36쪽, 전체 6쪽
- 주제분류
- 의약학 > 의학일반
- 파일형태
- 발행일자
- 2003.12.01
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
The aim of this study is to develop a simple method which computes in-vivo doses from transmission doses measured during patient treatment using an ionization chamber.
Energy fluence and the dose that reach the chamber positioned behind the patient is modified by three factors : patient attenuation, inverse square attenuation, and scattering. We adopted a straightforward empirical approach using a phantom transmission factor (PTF) which accounts for the contribution from all three factors. It was done as follows.
First of all, the phantom transmission factor was measured as a simple ratio of the chamber reading measured with and without a homogeneous phantom in the radiation beam according to various field sizes(r<SUB>p</SUB>) and phantom thickness(T<SUB>p</SUB>).
Secondly, we used the concept of effective field to the cases with irregular fields. The effective field size is calculated by finding the field size that produces the same value of PTF to that for the irregular field. The hypothesis is that the presence of irregular field can be accommodated to a certain extent by altering the field size. Thirdly, the center dose at the prescription depth can be computed using the new TMR(r<SUB>p,eff</SUB>) and Sp(r<SUB>p,eff</SUB>) from the effective field size. After that, when TMR(d, r<SUB>p,eff</SUB>) and Sp(r<SUB>p,eff</SUB>) are acquired, the tumor dose is as follows.
D<SUB>center</SUB> = D<SUB>t</SUB>/PTF(d<SUB>g</SUB>, T<SUB>p</SUB>) × ( SCD/SAD)² × S<SUB>p</SUB>(r<SUB>p,eff</SUB>) × TMR(d, r<SUB>p,eff</SUB>)
As the field size increased, the errors showed a tendency to increase. Generally, with this method the absolute midline dose was predicted with an accuracy of about 2.53% and 2.37% for 6 ㎹ and 10MV X-rays.
A simple method of in-vivo dose reconstruction and verification was developed. The efficacy of this method is limited by the field size. Thus, the method developed in this study should be used with care for relatively large field sizes. Further clinical test awaits this study.
Energy fluence and the dose that reach the chamber positioned behind the patient is modified by three factors : patient attenuation, inverse square attenuation, and scattering. We adopted a straightforward empirical approach using a phantom transmission factor (PTF) which accounts for the contribution from all three factors. It was done as follows.
First of all, the phantom transmission factor was measured as a simple ratio of the chamber reading measured with and without a homogeneous phantom in the radiation beam according to various field sizes(r<SUB>p</SUB>) and phantom thickness(T<SUB>p</SUB>).
Secondly, we used the concept of effective field to the cases with irregular fields. The effective field size is calculated by finding the field size that produces the same value of PTF to that for the irregular field. The hypothesis is that the presence of irregular field can be accommodated to a certain extent by altering the field size. Thirdly, the center dose at the prescription depth can be computed using the new TMR(r<SUB>p,eff</SUB>) and Sp(r<SUB>p,eff</SUB>) from the effective field size. After that, when TMR(d, r<SUB>p,eff</SUB>) and Sp(r<SUB>p,eff</SUB>) are acquired, the tumor dose is as follows.
D<SUB>center</SUB> = D<SUB>t</SUB>/PTF(d<SUB>g</SUB>, T<SUB>p</SUB>) × ( SCD/SAD)² × S<SUB>p</SUB>(r<SUB>p,eff</SUB>) × TMR(d, r<SUB>p,eff</SUB>)
As the field size increased, the errors showed a tendency to increase. Generally, with this method the absolute midline dose was predicted with an accuracy of about 2.53% and 2.37% for 6 ㎹ and 10MV X-rays.
A simple method of in-vivo dose reconstruction and verification was developed. The efficacy of this method is limited by the field size. Thus, the method developed in this study should be used with care for relatively large field sizes. Further clinical test awaits this study.
목차
Abstract
Ⅰ. 서론
Ⅱ. 재료 및 방법
Ⅲ. 결과 및 고찰
Ⅳ. 결론
참고문헌
Ⅰ. 서론
Ⅱ. 재료 및 방법
Ⅲ. 결과 및 고찰
Ⅳ. 결론
참고문헌
키워드
해당간행물 수록 논문
- 의료기관 간의 응급환자 기초정보 전달을 위한 시스템의 개발 및 구현
- 金邁淳의 《洌陽 歲時記》 硏究
- RAPD산물의 Direct Oligonucleotide Extension Sequencing을 이용한 쇠고기 품종 구분용 SCAR marker의 개발
- 노인의료서비스 개선방안에 관한 연구
- 골격근에서의 H₂O₂에 의한 세포사멸
- 보건의료정보 도입에 따른 교육프로그램 개발
- 8명의 한국인 남자 학생들에서 Sodium Valproate의 생체이용률 연구를 위한 HPLC 분석 방법의 개발
- 넓은 선속의 진단용 X선에 대한 건축재료의 차폐특성에 관한 연구
- 보건과학연구소 현황 외
- 폐쇄성 수면무호흡증환자의 혈장 단백에 대한 프로테옴 분석
- 방사선 치료 시 종양선량을 예측하는 방법에 관한 연구
참고문헌
관련논문
의약학 > 의학일반분야 BEST
- 아동․청소년대상 현실치료 집단상담 프로그램의 효과에 대한 메타분석
- 시뮬레이션 기반 결핵환자 간호교육이 간호대학생의 지식, 임상추론역량, 임상수행능력, 교육만족도에 미치는 효과
- 노인들의 원예활동이 생활만족도와 정서적 안정감에 미치는 영향
의약학 > 의학일반분야 NEW
- 간호대학생의 에너지 음료 섭취 실태, 위험 인식 및 섭취 관련 요인
- 아로마요법이 고등학생의 학업스트레스, 우울, 수면의 질 및 심박변이도에 미치는 효과
- 임상병리학 수업에서 Socrative 앱 기반 학습자 반응시스템의 적용 및 효과 분석
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!